FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceuticals and describes a method for producing a drug based on the sodium salt of 5-amino-2,3-dihydrophthalazine-1,4-dione (sodium aminodihydrophthalazinedione) in the form of a lyophilisate. The method includes preparing an aqueous solution of sodium aminodihydrophthalazinedione with a concentration of 03-250 mg / ml; carrying out sterilizing filtration of the resulting solution and dosing the sterile solution into the primary packaging; carrying out lyophilization. Freeze drying is carried out in several stages, while cooling is carried out to minus 75°C - minus 15°C at a rate of 0.5-10 ° C per minute and further drying is carried out until the moisture content in the product is not more than 10%. At the last stage, the freeze-drying chamber is filled with sterile air, sealed and the package is rolled up / sealed.
EFFECT: method according to the invention allows obtaining a stable and highly purified drug in the form of sodium aminodihydrophthalazinedione lyophilisate with increased ergonomics and conversion of the process.
2 cl, 2 tbl, 7 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MANUFACTURE OF NON-STERILE SUBSTANCES OF NON-AQUEOUS "TAMERIT" AND/OR DOUBLE-AQUEOUS "GALAVIT" - SODIUM SALTS OF 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE (VERSIONS) AND METHODS FOR FURTHER PROCESSING THEREOF TO OBTAIN STERILE MEDICINAL PREPARATIONS | 2016 |
|
RU2625267C1 |
METHOD FOR PRODUCING A MEDICINAL PRODUCT | 2020 |
|
RU2774615C1 |
METHOD FOR PRODUCING A MEDICINAL PRODUCT | 2020 |
|
RU2774597C1 |
METHOD OF OBTAINING ACTIVE PHARMACEUTICAL SUBSTANCE, PRESENTING AMINODIHYDROPHTHALAZINEDIONE OF SODIUM | 2017 |
|
RU2673452C1 |
RADIOPROTECTIVE, RADIOMITIGATORY AND RADIOSENSITIZING AGENT BASED ON SODIUM SALT OF AMINODIHYDROPHTHALAZINEDIONE SODIUM (DRUG TAMERON) AND OTHER ALKALI AND ALKALINE EARTH METAL SALTS OF AMINODIHYDROPHTHALAZINEDIONE | 2022 |
|
RU2804886C1 |
DRUG BASED ON 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE AS QUICK-SOLUBLE FILM FOR TRANSBUCCAL INTRODUCTION | 2017 |
|
RU2635769C1 |
METHOD OF DRUG PRODUCING | 2000 |
|
RU2155043C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF LYOPHILISATE WITH COMPLEXANT FOR PREPARATION OF SOLUTION FOR PARENTERAL APPLICATION AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2545902C1 |
METHOD FOR SUPPRESSING THE GROWTH OF B16 MELANOMA IN LABORATORY ANIMALS | 2022 |
|
RU2784443C2 |
METHOD OF PREPARING ALKALI AND ALKALI-EARTH SALTS OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE | 2000 |
|
RU2169139C1 |
Authors
Dates
2021-03-16—Published
2020-04-28—Filed